Here are five points:
1. North America has experienced a rise in aging population, more healthcare expenditure and a developed healthcare infrastructure.
2. Asia-Pacific is expected to see growth over the next five years, especially in China and India.
3. Developing countries will see growth due to a rising number of patients, increasing disposable income, rising geriatric population, increasing cases of brain tumors, growing healthcare expenditures and rising healthcare awareness.
4. Governments are also funding the creation of neurosurgical products.
5. Alternative treatments, strict regulatory requirements and lengthy approval time for products present obstacles to growth.
More articles on devices:
Rivanna Medical starts selling Accuro device: 5 things to know
$27.8B by 2022: 6 trends in the U.S. medical device outsourcing market
FDA approves Cerapedics bone graft for cervical spine — 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
